BDNF as a promising therapeutic agent in Parkinson's disease

E Palasz, A Wysocka, A Gasiorowska… - International journal of …, 2020 - mdpi.com
Brain-derived neurotrophic factor (BDNF) promotes neuroprotection and neuroregeneration.
In animal models of Parkinson's disease (PD), BDNF enhances the survival of dopaminergic …

N-3 (Omega-3) fatty acids: effects on brain dopamine systems and potential role in the etiology and treatment of neuropsychiatric disorders

M Healy-Stoffel, B Levant - CNS & Neurological Disorders …, 2018 - ingentaconnect.com
Background & Objective: A number of neuropsychiatric disorders, including Parkinson's
disease, schizophrenia, attention deficit hyperactivity disorder, and, to some extent …

Architecture and regulation of a GDNF-GFRα1 synaptic adhesion assembly

FM Houghton, SE Adams, AS Ríos, L Masino… - Nature …, 2023 - nature.com
Glial-cell line derived neurotrophic factor (GDNF) bound to its co-receptor GFRα1 stimulates
the RET receptor tyrosine kinase, promoting neuronal survival and neuroprotection. The …

Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and …

ATR Goes, CR Jesse, MS Antunes, FVL Ladd… - Chemico-biological …, 2018 - Elsevier
Chrysin is a natural flavonoid which is found in bee propolis, honey and various plants, and
neuroprotective effect of chrysin in mice was previously demonstrated by our group …

GDNF and the RET receptor in cancer: new insights and therapeutic potential

LM Mulligan - Frontiers in physiology, 2019 - frontiersin.org
The Glial cell line-derived neurotrophic Family Ligands (GFL) are soluble neurotrophic
factors that are required for development of multiple human tissues, but which are also …

Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia

K Mätlik, DR Garton, AR Montaño-Rodríguez… - Molecular …, 2022 - nature.com
Presynaptic increase in striatal dopamine is the primary dopaminergic abnormality in
schizophrenia, but the underlying mechanisms are not understood. Here, we hypothesized …

Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease

GA Badawi, MA Abd El Fattah, HF Zaki… - …, 2017 - Springer
The present study investigated the possible relationship between pro-inflammatory
cytokines and programmed nigral neuronal death in rotenone model of Parkinson's disease …

Regulation of GDNF expression in Sertoli cells

PA Parekh, TX Garcia, MC Hofmann - Reproduction, 2019 - rep.bioscientifica.com
Sertoli cells regulate male germ cell proliferation and differentiation and are a critical
component of the spermatogonial stem cell (SSC) niche, where homeostasis is maintained …

Explorative combined lipid and transcriptomic profiling of substantia nigra and putamen in Parkinson's disease

H Xicoy, JF Brouwers, B Wieringa, GJM Martens - Cells, 2020 - mdpi.com
Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons from the
substantia nigra (SN) that project to the dorsal striatum (caudate-putamen). To better …

Analysis of Acute and Chronic Methamphetamine Treatment in Mice on Gdnf System Expression Reveals a Potential Mechanism of Schizophrenia Susceptibility

L Casserly, DR Garton, A Montaño-Rodriguez… - Biomolecules, 2023 - mdpi.com
The increase in presynaptic striatal dopamine is the main dopaminergic abnormality in
schizophrenia (SCZ). SCZ is primarily treated by modulating the activity of monoamine …